Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · IEX Real-Time Price · USD
9.19
-0.20 (-2.13%)
At close: Apr 26, 2024, 4:00 PM
9.64
+0.45 (4.90%)
After-hours: Apr 26, 2024, 4:50 PM EDT
Adverum Biotechnologies Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for ADVM stock have an average target of 40, with a low estimate of 20 and a high estimate of 60. The average target predicts an increase of 335.26% from the current stock price of 9.19.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 19, 2024.
Analyst Ratings
The average analyst rating for ADVM stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 0 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Chardan Capital | Chardan Capital | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +335.26% | Mar 19, 2024 |
RBC Capital | RBC Capital | Hold Maintains $30 → $20 | Hold | Maintains | $30 → $20 | +117.63% | Mar 19, 2024 |
Mizuho | Mizuho | Strong Buy Maintains $20 → $40 | Strong Buy | Maintains | $20 → $40 | +335.26% | Feb 6, 2024 |
Mizuho | Mizuho | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +117.63% | Nov 2, 2023 |
Truist Securities | Truist Securities | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +552.88% | Sep 5, 2023 |
Financial Forecast
Revenue This Year
n/a
from 3.60M
Revenue Next Year
n/a
EPS This Year
-5.51
from -11.60
EPS Next Year
-5.53
from -5.51
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | 81.1M | 48.3M |
Avg | n/a | n/a | n/a | 39.3M | 22.4M |
Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 22.8% |
Avg | - | - | - | - | -43.0% |
Low | - | - | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -5.04 | -5.15 | -4.62 | -0.49 | -0.45 |
Avg | -5.51 | -5.53 | -5.00 | -0.74 | -0.66 |
Low | -5.89 | -5.88 | -5.39 | -1.03 | -0.84 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.